Meena Subramanyam

Meena Subramanyam is an accomplished professional in the biotechnology and pharmaceutical industries, with extensive experience spanning over three decades. At Takeda Oncology, from May 2017 to July 2025, Meena held several leadership roles, including Global Product Lead for Rusfertide and Vice President for Global Program Leadership across various therapeutic areas. Prior experience at Biogen included the role of Vice President of Translational Sciences and Technology, while earlier experience includes serving as Associate Director of Experimental Therapeutics at Ares Advanced Technology (Merck-Serono). Meena holds a Doctor of Philosophy (Ph.D.) in Microbiology and Immunology from Miami University and a Master of Science (MSc) in Medical Microbiology from the University of Madras, Post-Graduate Institute of Medical Sciences.